July 29, 2021 12:00 pm
Bharat Biotech on July 23 said it terminated the MoU it entered with Precisa Medicamentos and Envixia Pharmaceuticals LLC for its COVID-19 vaccine Covaxin for Brazilian market.
July 24, 2021 8:24 am
It is unclear at this stage whether the Hyderabad-based vaccine maker’s decision to terminate its November 24 contract with Precisa Medicamentos and Envixia Pharmaceuticals is a result of the controversy.
July 23, 2021 5:30 pm
Bharat's statement said it will continue to work with Brazilian healthcare regulator Anvisa to obtain all required approvals for the use of Covaxin in the country.
July 20, 2021 11:33 am
Suchitra Ella, joint managing director of Bharat Biotech, had recently said the EUL process is a step closer to the final decision on Covaxin's 'global acceptance' as the rolling data was slated to begin in July.
July 03, 2021 10:23 am
Pointing out that the deal is now being probed by a Parliament Senate panel of Brazil and two criminal investigating agencies, the party said the “taint comes all the way to ICMR also because it is a co-developer of the vaccine”.
June 30, 2021 9:49 pm
How many Covaxin doses have been administered in the country? Which states lead in Covaxin vaccinations? And how does Covaxin compare with Covishield in terms of doses used?
June 30, 2021 10:19 pm
"As of 29th June 2021, Bharat Biotech has not received any advance payments nor supplied any vaccines to Ministry of Health Brazil," the company statement reads.
June 29, 2021 8:07 am
In March, a Brazilian Health Ministry official, Luis Ricardo Miranda, informed President Bolsonaro about pressure being brought on him to buy Covaxin despite certain red flags that he had raised over purchasing a tranche of doses.
June 27, 2021 8:59 am
In its affidavit, the Centre said that based on supply estimates, it estimates 51.6 crore cumulative vaccinations by the end of July.
June 25, 2021 12:45 pm
Federal prosecutors and a special Senate committee are investigating the deal for Bharat Biotech's Covaxin shot, citing the fact that the government struck a speedy agreement when offers from Pfizer in 2020 at a lower price were ignored at the time.